Natural Alternatives International, Inc. Stock price

Equities

NAII

US6388423021

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
6.09 USD +0.16% Intraday chart for Natural Alternatives International, Inc. +2.35% -6.74%
Sales 2022 171M Sales 2023 154M Capitalization 43.74M
Net income 2022 10M Net income 2023 2M EV / Sales 2022 0.43 x
Net Debt 2022 10.01M Net Debt 2023 17.33M EV / Sales 2023 0.4 x
P/E ratio 2022
6 x
P/E ratio 2023
16.7 x
Employees 317
Yield 2022 *
-
Yield 2023
-
Free-Float 51.12%
More Fundamentals * Assessed data
Dynamic Chart
CarnoSyn®? Brands Partners with Barentz for Exclusive Brazilian Distribution of CarnoSyn®? Beta-Alanine CI
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q2 Revenue $25.2M MT
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q1 Revenue $34M MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011. CI
Natural Alternatives International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
North American Morning Briefing : Yield Surge -2- DJ
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q4 Revenue $35.9M MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011. CI
Natural Alternatives International, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
Natural Alternatives Temporarily Shuts New Facility in California; Staff Furlough Notice Issued; Shares Drop After Hours MT
Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs CI
Natural Alternatives International Appoints Shane Conti as New VP of Global Sales CI
Natural Alternatives International, Inc. Enters into A Fourth Amendment to Lease Amending and Extending the Term of the Lease of Its Vista California Manufacturing Facilities CI
Natural Alternatives International Adds New Manufacturing Unit in California MT
More news
1 day+0.16%
1 week+2.35%
Current month+0.83%
1 month+0.66%
3 months-5.43%
6 months-4.09%
Current year-6.74%
More quotes
1 week
5.97
Extreme 5.97
6.10
1 month
5.65
Extreme 5.65
6.11
Current year
5.65
Extreme 5.65
6.98
1 year
5.06
Extreme 5.06
9.44
3 years
5.06
Extreme 5.06
19.93
5 years
0.00
Extreme 0
19.93
10 years
0.00
Extreme 0
19.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 79-12-31
Director of Finance/CFO 47 08-03-31
President 63 08-01-31
Members of the board TitleAgeSince
Chief Executive Officer 70 79-12-31
Director/Board Member 69 03-12-31
Director/Board Member 60 21-09-16
More insiders
Date Price Change Volume
24-03-28 6.09 +0.16% 2,103
24-03-27 6.08 -0.33% 4,334
24-03-26 6.1 +1.50% 1,565
24-03-25 6.01 +0.17% 5,943
24-03-22 6 +0.84% 6,093

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company’s CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
More about the company
  1. Stock
  2. Equities
  3. Stock Natural Alternatives International, Inc. - Nasdaq